The industry launches the Berlin Declaration This link will open in a new window, presenting global leaders with a proposal that could help ensure that in future pandemics, vaccines, treatments and diagnostics are delivered as early as possible to vulnerable populations in low-income countries. This includes an offer from the industry to reserve an allocation of real-time production for distribution to priority populations in these countries. Later on 23 October 2022, the Biotechnology Innovation Organization (BIO), and the Developing Countries Vaccine Manufacturers' Network (DCVMN) will jointly endorse the Berlin Declaration framework.
Only 9 months after the Omicron variant was first identified, Moderna annouces that the UK has authorized its Omicron-specific vaccine This link will open in a new window, the first COVID-19 vaccine targeting Omicron to get approval worldwide.
Between 15 August and 1 September 2022, a number of countries have approved Pfizer and Moderna's updated COVID-19 boosters, including, UK, Switzlernand, Australia and US.